Secondary prevention. Pills without co-pay reduce complications after myocardial infarct
Einecke, D.
MMW Fortschritte der Medizin 153(48): 15
2011
ISSN/ISBN: 1438-3276 PMID: 22299244 Document Number: 653853
Document emailed within 1 workday
Related Documents
Follath, F. 1986: Secondary prevention following myocardial infarct Schweizerische Rundschau für Medizin Praxis 75(40): 1177-1180Bocková, E.; Polácková, J. 1985: Behavior pattern in the secondary prevention of myocardial infarct Ceskoslovenska Psychiatrie 81(2): 96-99
Schilling, J.; Schwendinger, M.; Vranjes, N.; Gutzwiller, F. 1996: Thrombolysis following myocardial infarct. European Secondary Prevention Study Praxis 85(42): 1311-1315
de Jonge, F.A.; Jonker, J.J. 1983: New study on the secondary prevention of myocardial infarct using oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 127(31): 1391-1394
Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G. 1997: Lipid lowering treatment in secondary prevention following myocardial infarct Orvosi Hetilap 138(29): 1849-1853
Di Pasquale, G.; Ottani, F.; Ceré, E.; Biancoli, S.; Sassone, B.; Lombardi, A. 1998: Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct Recenti Progressi in Medicina 89(10): 514-519
Bungeroth, K.A. 1987: Secondary prevention following myocardial infarct. Which drug treatment is safe today? Fortschritte der Medizin 105(31): 607-611
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Brown, E.J.; Erburu, L.; Kloner, R.A. 1987: Inability of fructose 1,6-diphosphate to reduce myocardial infarct size Journal of Medicine 18(1): 43-53
Schmidt-Habelmann, P.; Mayr, N.; Sebening, F. 1984: Surgically correctable complications of myocardial infarct Schweizerische Medizinische Wochenschrift 114(13): 426-430
Stoupel, E. 1982: Stress, causative factor of or secondary reaction to myocardial infarct Revue Medicale de Liege 37(Suppl 1): 25-28
De Teresa, R.C. 1974: Surgical treatment of various complications of acute myocardial infarct Gaceta Medica de Mexico 107(5): 379-382
Diener, H.C.; Weiller, C. 1993: Ticlopidine. Secondary prevention of ischemic cerebral infarct Der Internist 34(12): 1150-1155
Persico, S.; Chieffo, C.; Corsini, G.; Correale, E.; Tritto, C. 1976: Microcatheterization in the diagnosis of certain complications during the acute phase of myocardial infarct Bollettino Della Societa Italiana di Cardiologia 21(1): 169-178
Brouwer, M.H.; Parker, J.A.; Hamer, J.P.; van den Berg, M.P. 1999: Mechanical complications due to ischemic damage after an acute myocardial infarct Nederlands Tijdschrift Voor Geneeskunde 143(3): 129-133
Schauer, J.; Harksel, B.; Harksel, K. 1987: Effect of secondary bronchopulmonary diseases on the performance and course of rehabilitation of patients with myocardial infarct Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 42(7): 182-187
Syc, S.; Dobek, J.; Kondrak, R. 1975: Effect of hospital rehabilitation on the incidence of complications in patients with myocardial infarct Wiadomosci Lekarskie 28(13): 1105-1110
Komarov, F.I.; Lisovskiĭ, V.A.; Polozhentsev, S.D.; Baranovskiĭ, A.V.; Trofimov, G.A. 1975: Diagnostic value of determining lactate dehydrogenase isoenzymes in myocardial infarct complications Voenno-Meditsinskii Zhurnal 1: 41-44
Burkart, F. 1985: Prevention of myocardial infarct and of reinfarction Therapeutische Umschau. Revue Therapeutique 42(8): 511-520
Stepura, O.B. 1981: Glucocorticoid functional characteristics of the adrenals in the terminal complications of acute myocardial infarct Kardiologiia 21(12): 49-55